Expression of phosphofructokinase in skeletal muscle is influenced by genetic variation and associated with insulin sensitivity

Diabetes

Volumn 63, Issue 3, 2014, Pages 1154-1165

  Keildson, Sarah ^a   Fadista, Joao ^b   Ladenvall, Claes ^b   Hedman, Asa K ^a   Elgzyri, Targ ^b   Small, Kerrin S ^c,d   Grundberg, Elin ^c,d   Nica, Alexandra C ^e   Glass, Daniel ^c   Richards, J Brent ^c,f   Barrett, Amy ^g   Nisbet, James ^d   Zheng, Hou Feng ^f   Rönn, Tina ^b   Ström, Kristoffer ^b,h   Eriksson, Karl Fredrik ^b   Prokopenko, Inga ^a   Spector, Timothy D ^c   Dermitzakis, Emmanouil T ^e   Deloukas, Panos ^d   McCarthy, Mark I ^a,g,i   Rung, Johan ^j   Groop, Leif ^b   Franks, Paul W ^b   Lindgren, Cecilia M ^a,k   Hansson, Ola ^b   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b LUND UNIVERSITY DIABETES CENTRE   (Sweden)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^f MCGILL UNIVERSITY   (Canada)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h MID SWEDEN UNIVERSITY   (Sweden)

ⁱ CHURCHILL HOSPITAL   (United Kingdom)

^j EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^k BROAD INSTITUTE OF MIT AND HARVARD   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; AMINOPEPTIDASES; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI;

EID: 84894499261     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1301     Document Type: Article

References (54)

1. Mason CC, Hanson RL, Ossowski V, et al. Bimodal distribution of RNA expression levels in human skeletal muscle tissue. BMC Genomics 2011; 12:98
2. Fu J, Wolfs MG, Deelen P, et al. Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet 2012;8:e1002431
3. Abel ED, Peroni O, Kim JK, et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001;409: 729-733
4. Savage DB, Petersen KF, Shulman GI. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 2005;45:828-833
5. Szendroedi J, Phielix E, Roden M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 2012;8:92-103
6. Dresner A, Laurent D, Marcucci M, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999;103:253-259
7. Elgzyri T, Parikh H, Zhou Y, et al. First-degree relatives of type 2 diabetic patients have reduced expression of genes involved in fatty acid metabolism in skeletal muscle. J Clin Endocrinol Metab 2012;97:E1332-E1337
8. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267-273
9. Tripathy D, Eriksson KF, Orho-Melander M, Fredriksson J, Ahlqvist G, Groop L. Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes. Diabetologia 2004;47:782-793
10. Moayyeri A, Hammond CJ, Hart DJ, Spector TD. The UK Adult Twin Registry (TwinsUK Resource). Twin Res Hum Genet 2013;16:144-149
11. Shabalin AA. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 2012;28:1353-1358
12. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010;26:2190-2191
13. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003;100:9440-9445
14. Nica AC, Parts L, Glass D, et al.; MuTHER Consortium. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet 2011;7:e1002003
15. Al-Kafaji G, Malik AN. Hyperglycemia induces elevated expression of thyroid hormone binding protein in vivo in kidney and heart and in vitro in mesangial cells. Biochem Biophys Res Commun 2010;391:1585-1591
16. Boyle AP, Hong EL, Hariharan M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012;22:1790-1797
17. Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4:44-57
18. Yang TP, Beazley C, Montgomery SB, et al. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics 2010;26:2474-2476
19. Morris AP, Voight BF, Teslovich TM, et al.; Wellcome Trust Case Control Consortium; Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators; Genetic Investigation of ANthropometric Traits (GIANT) Consortium; Asian Genetic Epidemiology Network-Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012;44:981-990
20. Dupuis J, Langenberg C, Prokopenko I, et al.; DIAGRAM Consortium; GIANT Consortium; Global BPgen Consortium; Anders Hamsten on behalf of Procardis Consortium; MAGIC investigators. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105-116
21. Scott RA, Lagou V, Welch RP, et al.; DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 2012;44:991-1005
22. Das SK, Chu W, Zhang Z, Hasstedt SJ, Elbein SC. Calsquestrin 1 (CASQ1) gene polymorphisms under chromosome 1q21 linkage peak are associated with type 2 diabetes in Northern European Caucasians. Diabetes 2004;53:3300-3306
23. Burgdorf KS, Gjesing AP, Grarup N, et al. Association studies of novel obesity-related gene variants with quantitative metabolic phenotypes in a population-based sample of 6,039 Danish individuals. Diabetologia 2012;55:105-113
24. Lee CH, Chu NF, Shieh YS, Hung YJ. The growth arrest-specific 6 (Gas6) gene polymorphism c.834+7G.A is associated with type 2 diabetes. Diabetes Res Clin Pract 2012;95:201-206
25. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223
26. Galgani JE, Moro C, Ravussin E. Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab 2008;295:E1009-E1017
27. Gallagher IJ, Scheele C, Keller P, et al. Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med 2010;2:9
28. Jin W, Goldfine AB, Boes T, et al. Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance. J Clin Invest 2011;121:918-929
29. van Tienen FH, Praet SF, de Feyter HM, et al. Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes. J Clin Endocrinol Metab 2012;97:3261-3269
30. Gordon PM, Liu D, Sartor MA, et al. Resistance exercise training influences skeletal muscle immune activation: a microarray analysis. J Appl Physiol (1985) 2012;112:443-453
31. Palsgaard J, Brøns C, Friedrichsen M, et al. Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways. PLoS One 2009;4: e6575
32. Park JJ, Berggren JR, Hulver MW, Houmard JA, Hoffman EP. GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Physiol Genomics 2006;27:114-121
33. Pihlajamäki J, Lerin C, Itkonen P, et al. Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis. Cell Metab 2011;14:208-218
34. Skov V, Glintborg D, Knudsen S, et al. Reduced expression of nuclearencoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes 2007;56:2349-2355
35. Skov V, Glintborg D, Knudsen S, et al. Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome. PLoS ONE 2008;3:e2466
36. Stephens NA, Gallagher IJ, Rooyackers O, et al. Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome Med 2010;2:1
37. Innocenti F, Cooper GM, Stanaway IB, et al. Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissue. PLoS Genet 2011;7:e1002078
38. Veyrieras JB, Kudaravalli S, Kim SY, et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet 2008;4:e1000214
39. Cifaldi L, Romania P, Lorenzi S, Locatelli F, Fruci D. Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer. Int J Mol Sci 2012;13:8338-8352
40. Dimas AS, Deutsch S, Stranger BE, et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 2009; 325:1246-1250
41. Grundberg E, Small KS, Hedman AK, et al.; Multiple Tissue Human Expression Resource (MuTHER) Consortium. Mapping cis-and transregulatory effects across multiple tissues in twins. Nat Genet 2012;44: 1084-1089
42. Montgomery SB, Dermitzakis ET. From expression QTLs to personalized transcriptomics. Nat Rev Genet 2011;12:277-282
43. Heid IM, Jackson AU, Randall JC, et al.; MAGIC. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 2010;42: 949-960
44. Nakajima H, Noguchi T, Yamasaki T, Kono N, Tanaka T, Tarui S. Cloning of human muscle phosphofructokinase cDNA. FEBS Lett 1987;223: 113-116
45. Felber JP, Vannotti A. Effects of fat infusion on glucose tolerance and insulin plasma levels. Med Exp Int J Exp Med 1964;10:153-156
46. Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 2000;49:677-683
47. Russell RD, Kraemer RR, Nelson AG. Metabolic dysfunction in diabetic offspring: deviations in metabolic flexibility. Med Sci Sports Exerc 2013;45: 8-15
48. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1991;72:96-107
49. Simoneau JA, Colberg SR, Thaete FL, Kelley DE. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J 1995;9: 273-278
50. Bass A, Vondra K, Rath R, Vítek V, Havránek T. Metabolic changes in the quadriceps femoris muscle of obese people. Enzyme activity patterns of energy-supplying metabolism. Pflugers Arch 1975;359: 325-334
51. Simoneau JA, Kelley DE. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol (1985) 1997;83:166-171
52. Lithell H, Lindgärde F, Hellsing K, et al. Body weight, skeletal muscle morphology, and enzyme activities in relation to fasting serum insulin concentration and glucose tolerance in 48-year-old men. Diabetes 1981;30:19-25
53. Oberbach A, Bossenz Y, Lehmann S, et al. Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care 2006;29: 895-900
54. Krotkiewski M, Bylund-Fallenius AC, Holm J, Björntorp P, Grimby G, Mandroukas K. Relationship between muscle morphology and metabolism in obese women: the effects of long-term physical training. Eur J Clin Invest 1983;13:5-12